Verastem (VSTM) Interest & Investment Income (2012 - 2026)
Verastem (VSTM) posted quarterly Interest & Investment Income of $1.3 million for Q1 2026, up 35.1% year-over-year from $960000.0 in Q1 2025, and up 17.48% quarter-over-quarter from $1.1 million in Q4 2025.
Powered by 
Analysis
Verastem (VSTM) Interest & Investment Income (2012 - 2026) Analysis & Trends
Verastem's Interest & Investment Income history runs 15 years deep, the most recent figure standing at $1.3 million for Q1 2026.
- In Q1 2026, Interest & Investment Income rose 35.1% year-over-year to $1.3 million; the TTM figure through Mar 2026 stood at $4.4 million (up 17.72% YoY), while the FY2025 annual figure was $4.1 million, down 1.95% from the prior year.
- Interest & Investment Income for Q1 2026 stood at $1.3 million, up from $1.1 million in the prior quarter.
- The five-year high for Interest & Investment Income was $2.2 million in Q3 2023, with the low at $46000.0 in Q1 2022.
- The 5-year median for Interest & Investment Income is $976000.0 (2023), against an average of $996647.1.
- The sharpest annual moves came in 2023 and 2024: Interest & Investment Income surged 2021.74% in 2023, then sank 63.02% in 2024.
- Verastem's Interest & Investment Income stood at $769000.0 in 2022, then soared by 143.04% to $1.9 million in 2023, then sank by 48.21% to $968000.0 in 2024, then gained by 14.05% to $1.1 million in 2025, then rose by 17.48% to $1.3 million in 2026.
- Business Quant data shows VSTM's Interest & Investment Income at $1.3 million in Q1 2026, $1.1 million in Q4 2025, and $1.2 million in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.31 Bn | 131.46 Bn | 2.84 Bn | 120.60 Mn |
| 2 | Regeneron Pharmaceuticals | 85.65 Bn | 77.66 Bn | 3.93 Bn | -48.00 Mn |
| 3 | Argenx Se | 63.46 Bn | 58.27 Bn | 1.37 Bn | 48.00 Mn |
| 4 | Moderna | 57.94 Bn | 52.80 Bn | 52.00 Mn | 67.00 Mn |
| 5 | Revolution Medicines | 44.05 Bn | 44.05 Bn | - | 35.58 Mn |
| 6 | BeOne Medicines | 39.96 Bn | 34.86 Bn | 1.53 Bn | 27.90 Mn |
| 7 | Alnylam Pharmaceuticals | 35.16 Bn | 31.85 Bn | 992.69 Mn | 28.14 Mn |
| 8 | Royalty Pharma | 28.44 Bn | 27.60 Bn | - | 5.13 Mn |
| 9 | Insmed | 27.32 Bn | 26.16 Bn | 358.27 Mn | 10.98 Mn |
| 10 | Verastem | 789.92 Mn | 653.56 Mn | 36.32 Mn | 1.11 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.11 Mn |
| Mar 31, 2026 | 1.30 Mn |
| Dec 31, 2025 | 1.10 Mn |
| Sep 30, 2025 | 1.18 Mn |
| Jun 30, 2025 | 822,000.00 |
| Mar 31, 2025 | 960,000.00 |
| Dec 31, 2024 | 968,000.00 |
| Sep 30, 2024 | 831,000.00 |
| Jun 30, 2024 | 983,000.00 |
| Mar 31, 2024 | 1.37 Mn |
| Dec 31, 2023 | 1.87 Mn |
| Sep 30, 2023 | 2.25 Mn |
| Jun 30, 2023 | 1.12 Mn |
| Mar 31, 2023 | 976,000.00 |
| Dec 31, 2022 | 769,000.00 |
| Sep 30, 2022 | 316,000.00 |
| Jun 30, 2022 | 84,000.00 |
| Mar 31, 2022 | 46,000.00 |
| Dec 31, 2021 | 40,000.00 |
| Sep 30, 2021 | 40,000.00 |